For citations:

Ivanov R.A., Murashkin N.N. Administration Details of Genetically Engineered Biologic Drug (Ustekinumab) in Children with Psoriasis and Comorbid Metabolic Syndrome or in Case of Previous Biological Therapy Failure: Case Studies. Current Pediatrics. 2022;21(5):419-429. (In Russ.) https://doi.org/10.15690/vsp.v21i5.2458